Mixing doses of the Pfizer-BioNTech and AstraZeneca-Oxford vaccines generate a stronger immune response than having two rounds of the AstraZeneca shot, new U.K. research suggests, though the highest antibody response was seen in people being fully vaccinated with Pfizer.
The early findings, which haven’t yet been peer-reviewed, were released as a paper published online by the Lancet on Monday.
The results come from the University of Oxford-led Com-COV study, which is exploring the use of different combinations of approved COVID-19 vaccines.
This round of research looked at several vaccine combinations: two doses of Pfizer, two of AstraZeneca, and mixing doses with either AstraZeneca or Pfizer as the first shot and the other for the second.
“The mixed schedules did generate an immune response that was above the threshold set by the [AstraZeneca] vaccine, which we know is very effective against severe disease,” said the study’s chief investigator, Dr. Matthew Snape, an associate professor in pediatrics and vaccinology at the University of Oxford, during an interview with CBC News.
Both mixed schedules produced stronger responses than two doses of AstraZeneca, but the research team observed the highest antibody response in people receiving two doses of the Pfizer vaccine.
“Whether that translates into better protection or longer duration, we will have to see,” Snape said.
An AstraZeneca shot followed by Pfizer produced the best T-cell responses, the team found, and also a higher antibody response than Pfizer followed by AstraZeneca.
The results were for two doses of different vaccine combinations, given at four-week intervals to 830 people, in a participant-blind, non-inferiority trial — a type of study used to demonstrate that an experimental treatment is not substantially worse than an active treatment it’s being compared to.
Snape said he was surprised by the finding that the order of vaccines being used in the mixed schedules seemed to matter “quite a lot.”
When covid-19 struck Europe in March 2020, hospitals were plunged into a health crisis that was still badly understood. “Doctors really didn’t have a clue how to manage these patients,” says Laure Wynants, an [...]
Pfizer found to be 88 per cent effective at preventing symptomatic disease from delta variant. Two doses of Pfizer-BioNTech or AstraZeneca-Oxford's COVID-19 vaccines are nearly as effective against the highly transmissible delta coronavirus variant [...]
South African pharmaceutical company Aspen said Monday it was releasing its first batch of African-produced COVID-19 vaccines under a licensing deal with the US giant Johnson & Johnson. The Durban-based company said the first [...]
Since the coronavirus pandemic shut down the world, scientists have clamored to develop vaccines to prevent the spread and medicines that will cure the sick. But a virus’ main goal is to replicate and [...]
The highly transmissible delta variant of SARS-CoV-2, the coronavirus causing the disease COVID-19, is now present in 124 countries and will become the dominant strain globally in the coming months as it is outcompeting [...]
Scientists have backed proposals for Covid boosters in the autumn after blood tests on hundreds of people revealed that protective antibodies can wane substantially within weeks of second vaccine shots being given. Falls in [...]
Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall [...]
CSIRO, Australia's national science agency, played an important role in evaluating heat-tolerant COVID-19 vaccine formulations developed by the Indian Institute of Science (IISc) and biotech start-up Mynvax—against all current SARS-CoV-2 variants of concern. Published [...]
Podcast – Nanovisaging 2040 How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit Humanity
Frank Boehm (NanoApps Medical Inc. Founder) in discussion with Nana Kay in a Wealth Secrets podcast. EP 19. Nanovisaging 2040. From Nana Kay: Nanovisaging 2040: How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit [...]
Canada, like several other countries, has been mixing and matching COVID-19 vaccines for weeks amid safety concerns over the AstraZeneca shot. On Monday, the chief scientist at the World Health Organization (WHO) cautioned against that approach, calling [...]
Scientists have harnessed CRISPR gene-editing technology to block the replication of the novel coronavirus in human cells — an approach that could one day serve as a new treatment for COVID-19. However, the study was performed [...]
A recent study by scientists from Japanese universities has shown that the shape of cell-derived nanoparticles, known as "extracellular vesicles" (EVs), in body fluids could be a biomarker for identifying types of cancer. In [...]
An important lesson for vaccine design Australian scientists researching how our immune system responds to COVID-19 have revealed that those infected by early variants in 2020 produced sustained antibodies, however, these antibodies are not [...]
1. How COVID-19 is affecting the globe Confirmed cases of COVID-19 have passed 185 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4 million. More than 3.29 [...]
The World Health Organization (WHO) has added another COVID strain to its list of coronavirus variants to keep an eye on: the COVID-19 Lambda variant. This particular variant has now spread to more than two dozen [...]